Investing News COVID medicine reduces the risk of mortality and respiratory failure in trials, Biophytis shares increased by 45% September 7, 2022
Investing News BioVie increases by 21% after Phase 2 data report for Alzheimer’s test case September 7, 2022
Investing News Innovent dosages enrolls the first patient in the higher-dose cohort in the phase 2 obesity treatment trial September 5, 2022
Investing News Sorrento’s Back Pain Treatment Receives “Fast Track” Status From the FDA September 1, 2022
Investing News CBD Life Sciences, Inc. Announces Launch of New Product: Infused Gummies August 19, 2022
Investing News Moderna Appoints a New CFO Following the Abrupt Departure of the Former CFO August 18, 2022
Investing News Abbvie Has Decided to End Its Phase 1 Study of I-Anti-CD47 Mab’s Therapy for Cancer Treatment. August 17, 2022